BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17016646)

  • 1. Effects of RNAi-mediated Smad4 silencing on growth and apoptosis of human rhabdomyosarcoma cells.
    Ye L; Zhang H; Zhang L; Yang G; Ke Q; Guo H; Bu H
    Int J Oncol; 2006 Nov; 29(5):1149-57. PubMed ID: 17016646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentiviral-mediated Smad4 RNAi induced anti-proliferation by p16 up-regulation and apoptosis by caspase 3 down-regulation in hepatoma SMMC-7721 cells.
    Huang S; Zhang F; Miao L; Zhang H; Fan Z; Wang X; Ji G
    Oncol Rep; 2008 Nov; 20(5):1053-9. PubMed ID: 18949401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of transforming growth factor-beta/Smad signaling on the growth and apoptosis of human rhabdomyosarcoma cell line RD].
    Ye L; Zhang HY; Yang GH; Bu H; Guo H
    Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):407-12. PubMed ID: 16251045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
    Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
    Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells.
    Deckers M; van Dinther M; Buijs J; Que I; Löwik C; van der Pluijm G; ten Dijke P
    Cancer Res; 2006 Feb; 66(4):2202-9. PubMed ID: 16489022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
    Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
    J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta suppressed Id-1 Expression in a smad3-dependent manner in LoVo cells.
    Song H; Guo B; Zhang J; Song C
    Anat Rec (Hoboken); 2010 Jan; 293(1):42-7. PubMed ID: 19798702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta-mediated tumor necrosis factor-related apoptosis-inducing ligand expression and apoptosis in hepatoma cells requires functional cooperation between Smad proteins and activator protein-1.
    Herzer K; Grosse-Wilde A; Krammer PH; Galle PR; Kanzler S
    Mol Cancer Res; 2008 Jul; 6(7):1169-77. PubMed ID: 18644981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
    Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
    Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
    Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
    Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 inhibits the growth and metastasis of tongue squamous carcinoma cells through Smad4.
    Wang X; Sun W; Zhang C; Ji G; Ge Y; Xu Y; Zhao Y
    Gene; 2011 Oct; 485(2):160-6. PubMed ID: 21726607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved Smad4 expression in the transforming growth factor beta signaling pathway is a favorable prognostic factor in patients with advanced gastric cancer.
    Xiangming C; Natsugoe S; Takao S; Hokita S; Ishigami S; Tanabe G; Baba M; Kuroshima K; Aikou T
    Clin Cancer Res; 2001 Feb; 7(2):277-82. PubMed ID: 11234879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
    Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
    Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrovirus-based system to stably silence GDF-8 expression and enhance myogenic differentiation in human rhabdomyosarcoma cells.
    Yang Z; Zhang J; Cong H; Huang Z; Sun L; Liu C; Tien P
    J Gene Med; 2008 Aug; 10(8):825-33. PubMed ID: 18563849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single small-interfering RNA expression vector for silencing multiple transforming growth factor-beta pathway components.
    Jazag A; Kanai F; Ijichi H; Tateishi K; Ikenoue T; Tanaka Y; Ohta M; Imamura J; Guleng B; Asaoka Y; Kawabe T; Miyagishi M; Taira K; Omata M
    Nucleic Acids Res; 2005 Aug; 33(15):e131. PubMed ID: 16113239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.